(Q45290517)

11 December 2017

title

Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate (English)

1 reference

11 December 2017

1 reference

2

1 reference

11 December 2017

Serdar Pasa

1

1 reference

11 December 2017

Huseyin Voyvoda

series ordinal

3

1 reference

11 December 2017

Yusuf Ozbel

series ordinal

4

1 reference

11 December 2017

publication date

1 March 2005

1 reference

11 December 2017

published in

Veterinary Parasitology

1 reference

11 December 2017

volume

128

1 reference

11 December 2017

issue

3-4

1 reference

11 December 2017

page(s)

243-249

1 reference

Chemotherapy of canine leishmaniosis.

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2004.12.002

A retrospective clinical study of canine leishmaniasis in 150 dogs naturally infected by Leishmania infantum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2004.12.002

Serological diagnosis and treatment of canine leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2004.12.002

Decreased sensitivity to meglumine antimoniate (Glucantime) ofLeishmania infantumisolated from dogs after several courses of drug treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2004.12.002

A randomised, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2004.12.002

Studies on canine leishmaniasis control. 1. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2004.12.002

The synergistic action of pyrazolopyrimidines and pentavalent antimony against Leishmania donovani and L. braziliensis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2004.12.002

Exploitation of parasite-derived antigen in therapeutic success against canine visceral leishmaniosis. Veterinary Group of Lupino

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2004.12.002

Epidemiology, diagnosis and control of leishmaniasis in the Mediterranean region.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2004.12.002

Serodiagnosis and epidemiology of visceral leishmaniasis in Turkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2004.12.002

Urinary protein/creatinine ratio in the evaluation of renal failure in canine leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2004.12.002

Analysis of immune responses in dogs with canine visceral leishmaniasis before, and after, drug treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2004.12.002

Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2004.12.002

Serum concentrations of acute phase proteins in dogs with leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2004.12.002

Antibody kinetics during allopurinol treatment in canine leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2004.12.002

Follow-up of Leishmania infantum naturally infected dogs treated with allopurinol: immunofluorescence antibody test, ELISA and Western blot

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2004.12.002

Failure of buparvaquone (Butalex) in the treatment of canine visceral leishmaniosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2004.12.002

10.1016/J.VETPAR.2004.12.002

7 January 2021

Identifiers

DOI

1 reference

11 December 2017

1 reference